Physiologic effects of aging include structural and functional changes to the cardiovascular system, affecting chronic condition risk and pharmacokinetic and pharmacodynamic changes. PGx guidance exists for several cardiovascular conditions, with concentrations in antiplatelet, statin, beta-blocker, and anticoagulation therapies. Case scenarios are proposed and explored to illustrate how PGx data can inform treatment plans through appropriate integration of genetic and other factors.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Pharmacogenomics and Cardiovascular Care for Older Adults

  • Casey Rowe,
  • Elina Delgado,
  • Yee Ming Lee,
  • David Bright,
  • Youssef Roman

摘要

Physiologic effects of aging include structural and functional changes to the cardiovascular system, affecting chronic condition risk and pharmacokinetic and pharmacodynamic changes. PGx guidance exists for several cardiovascular conditions, with concentrations in antiplatelet, statin, beta-blocker, and anticoagulation therapies. Case scenarios are proposed and explored to illustrate how PGx data can inform treatment plans through appropriate integration of genetic and other factors.